All AbMole products are for research use only, cannot be used for human consumption.
NLRP3 Inflammasome Inhibitor I, an intermediate substrate in the synthesis of glyburide which is free of the cyclohexylurea moiety involved in insulin release, is a novel inhibitor of the NLRP3 inflammasome.
Molecular Weight | 368.84 |
Formula | C16H17ClN2O4S |
CAS Number | 16673-34-0 |
Solubility (25°C) | DMSO 73 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Ayesha Zahid, et al. Front Immunol. Pharmacological Inhibitors of the NLRP3 Inflammasome
[5] Stefano Toldo, et al. Nat Rev Cardiol. The NLRP3 inflammasome in acute myocardial infarction
Related Immunology/Inflammation Products |
---|
SMS121
SMS121 is a novel CD36 inhibitor. SMS121 reduced the uptake of fatty acid into AML cells that could be reversed by addition of free fatty acids and caused decreased cell viability. |
Rolistobart
Rolistobart is a humanized immunoglobulin G4-kappa, anti-LILRB4/CD85k monoclonal antibody. |
Gemtuzumab
Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin. |
Cyclosporin A-d4
Cyclosporin A-d4 |
Mycophenolic acid-13c,d3
Mycophenolic acid-13c,d3 |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.